Content about LONDON

LONDON — GlaxoSmithKline is acquiring the remainder of a privately owned research and development company, GSK said Tuesday.

The British drug maker announced that it would buy the shares of Cellzome it doesn't already own for $99 million. Cellzome has labs in the United Kingdom and Germany, and will become part of GSK's research and development organization. The company, of which GSK currently owns 19.98%, develops technologies for profiling compounds in cells and patient samples.

CINCINNATI — Through its beauty brands, Procter & Gamble has announced its pledge to donate $400,000 to the P&G|Team USA Youth Sports Fund to enrich and support youth sports programs across the country.

P&G's commitment to youth sports expands on its partnership with USA Gymnastics, Alicia Sacramone and Natalie Coughlin for the London 2012 Olympic Games, and its global marketing partnership with the International Olympic Committee through the 2020 Olympic Games.

CINCINNATI — Procter & Gamble, a worldwide Olympic partner, has launched its global P&G "Thank You Mom" campaign in celebration of 100 days to go until the opening ceremony of the London 2012 Olympic Games.

The campaign recognizes and celebrates the moms behind the athletes by thanking moms for all they do, and is a part of P&G’s worldwide partnership with the International Olympic Committee. It marks the biggest campaign in P&G’s 174-year history and will run from now through the end of the Olympic Games.

LONDON — Evidence supporting the daily use of aspirin to help prevent and possibly treat cancer was published Tuesday in a collection of three papers — two in The Lancet and one in Lancet Oncology.

SIKESTON, Mo. — Sabona of London has expanded its line of jewelry to include a leather magnetic necklace.

The necklace features a braided leather cord, available in brown or black, and holds four 1200 -gauss magnets in polished stainless steel accents. In addition to the necklace, the company also is rolling out several new bracelets, including:

• Imperial men's magnetic bracelet, featuring brushed and polished stainless steel;

• Greek Key men's stainless magnetic bracelet, showcasing the seamless Greek Key design;

LONDON — The global market for celiac disease is expected to grow substantially over the decade as more people are diagnosed with the condition, according to a new report.

The report, by British market research firm GlobalData, found that the global celiac disease therapeutics market would be worth more than $512 million by 2017 and $664.4 million by 2019.

NEW YORK — Procter & Gamble’s Pantene hair care brand will support 11 female athletes as its newest beauty ambassadors. The group will be featured in Pantene’s first global marketing campaign to support the Olympic Games.

LONDON — Patent expirations of key blockbuster drugs and efforts by payers to contain costs are likely to bring strong growth to the global generic drug market in the next few years as market-earned revenues grow by more than $100 billion, according to an analysis by research firm Frost & Sullivan.

The report, titled "Generic Pharmaceuticals Market — A Global Analysis" and focusing on the United States and Europe, also found that healthcare expenditure and sales revenues are poised to shift to India, China, Brazil, Turkey and South Korea.

WASHINGTON and LONDON — BareMinerals has announced that it will launch in February its first-ever global marketing campaign, dubbed “Be a Force of Beauty.”

Rooted in the company’s 35-year history, “Be a Force of Beauty” amplifies the core belief that beauty can change the world, both by inspiring positivity and activating women to put beauty into action.

LONDON — New research on a rare genetic disorder in which the pancreas fails to grow could shed light on how the organ develops and lead to treatments for Type 1 diabetes.

In a study published in the journal Nature Genetics, an international team of researchers led by scientists at England's University of Exeter discovered a genetic mutation present in 15-in-27 people with a condition called pancreatic agenesis, finding a key role for the gene, GATA6, in the development of pacreatic cells.

LONDON — Pfizer soon may lose its distinction of having the highest global sales of any drug company, according to life sciences industry analysis firm EvaluatePharma.

The next contender for the title is France's Sanofi, which EvaluatePharma said was expected to take the top spot next year and stay there through 2016.